Hope Biosciences Autologous Mesenchymal Stem Cell Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hope Biosciences Autologous Mesenchymal Stem Cell Therapy, covering 2026-01-15 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy [Phase 1, Phase 2]